top of page

Brazil: ANVISA Announces to Extend B-GMP Certificates for MDSAP-Certified Medical Device Manufacturers (w.e.f 1 April 2024)

On 20 March 2024, ANVISA published Resolution RDC 850/2024 with an official announcement to extend the Brazil Good Manufacturing Practices (B-GMP) Certificate from two (2) to four (4) years applicable to all medical device manufacturers under the Medical Device Single Audit Program (MDSAP).

This enforcement enters into force on 1 April 2024 and it will only benefit the new certificates issued and any B-GMP certificate holders undergoing renewal requests waiting for ANVISA approval before enforcing the Resolution. Hence, those manufacturers with 2-year B-GMP certificate issuance will remain the same until the next renewal.

Class III and IV medical device manufacturers were required to obtain a B-GMP certificate in Brazil. The certificate extension helps manufacturers reduce their regulatory fees and also enhances the benefits of the MDSAP certification.


Contact us at for more information.

Recent Posts

See All

Central & South America - Nov/Dec 2019

Brazil: Requirements finalized for custom-made and patient-specific medical devices Brazil: Proposed changes to requirements for syringes and infusion/transfusion pump sets Ecuador: Technical Regulati

Central & South America - Aug 2019

Brazil: Parametric release may replace sterility test for ethylene oxide sterilised devices Ecuador: Proposed revision of PRTE INEN No 186 concerning electromedical equipment and systems Mexico: Compu


bottom of page